Benjamin Kaplan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Miami, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Benjamin Kaplan
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Benjamin Kaplan

Form 4 holding CEO, Director

Mycotopia Therapies, Inc.

Security class
Common Stock
Shares / value
20,250,000
Estimated value
$283,500
Report date
13 Dec 2024
Price
$0.0140
Ownership
Direct
Form 4 holding Shares received in Merger

Community Redevelopment Inc.

Security class
Common Stock
Shares / value
1,666,667
Estimated value
Report date
23 Feb 2021
Price
Ownership
B.O. LONGSIDE VENTURES LLC

Insider Reports Filed by Benjamin Kaplan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .